Sandy is a Venture Partner working with the Medicxi investment team. He has an extensive background in corporate partnering, business development, operations and capital raising. Sandy currently plays an active role in several Index Ventures and Medicxi portfolio companies to support their development, including Chairman of both Janpix and Palladio.
Sandy has over 28 years experience as a senior executive in the life sciences industry. He was the Founder and CEO of both Nuvelution Pharma and Ascendancy Healthcare. He was also a Partner at Reedland Capital Partners, where he headed its life sciences M&A and advisory efforts, and a Managing Director of Bay City Capital, where he was President of the firm’s M&A and financing divisions. Sandy was also President and CFO of Epoch Biosciences (acquired by Nanogen in 2004).
Sandy received a BA in Biology from UC San Diego and an MS in Human Physiology from UC Davis. He is currently Senior Advisor to Nuvelution Pharma and serves on the Board of Directors of IMIDomics, Compugen (NASDAQ:CGEN) and Essa Pharma (NASDAQ:EPIX).